Is azithromycin safe for a woman of reproductive age who is trying to conceive, and is any waiting period required after completing therapy before attempting pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Azithromycin Use When Trying to Conceive

Azithromycin is safe for women trying to conceive and no waiting period is required after completing therapy before attempting pregnancy. 1, 2

Safety Profile for Women of Reproductive Age

Azithromycin is classified as FDA Pregnancy Category B and is the CDC's preferred macrolide antibiotic for use during pregnancy, including the first trimester. 1, 3 This classification means:

  • Animal reproduction studies at doses up to 4 times (rats) and 2 times (mice) the standard human dose showed no evidence of fetal harm 3
  • The European Respiratory Society classifies it as B1-category ("probably safe"), with limited human data showing no increase in fetal malformations 1
  • A prospective cohort study of 123 women exposed to azithromycin during pregnancy (71.6% in first trimester) found no statistically significant increase in major malformations compared to controls: 3.4% versus 2.3% (disease-matched controls) and 3.4% (non-teratogen controls) 4

No Waiting Period Required

Unlike drugs such as methotrexate, leflunomide, or cyclophosphamide that require washout periods before conception, azithromycin does not require any waiting period after treatment completion. 5 You can attempt pregnancy immediately after finishing the antibiotic course.

Clinical Context: Treatment During Early Pregnancy

The evidence strongly supports azithromycin safety even during established pregnancy:

  • The CDC recommends azithromycin 1g orally as first-line therapy for chlamydial infections during pregnancy, with cure rates of 94-100% versus 64-77% for erythromycin 2, 6
  • This represents an upgrade from the 1998 CDC guidelines (which listed it only as an alternative) to the 2006 guidelines (which made it first-line) based on accumulated safety and efficacy data 2
  • The CDC specifically states: "Do not withhold azithromycin in the first trimester when clinically indicated, as evidence does not support excessive caution" 2

Important Caveats and Contraindications

What Azithromycin Should NOT Be Used For:

  • Syphilis treatment: Azithromycin lacks sufficient efficacy for treating syphilis in pregnancy; penicillin remains the only proven therapy 1, 2

Drugs to Avoid (Not Azithromycin):

  • Doxycycline, ofloxacin, levofloxacin: Absolutely contraindicated during pregnancy due to teratogenicity 5, 6
  • Clarithromycin: A known animal teratogen and should never be substituted for azithromycin 1
  • Erythromycin estolate: Contraindicated due to hepatotoxicity risk 5, 6

Conflicting Evidence Acknowledgment

A 2022 narrative review noted conflicting results across studies, with some reporting increased risks of spontaneous miscarriage, congenital malformations, or preterm birth, while others found no such associations 7. However, the review concluded there is no conclusive evidence that azithromycin causes adverse offspring outcomes 7. A 2024 animal study in mice suggested potential testicular developmental effects at high doses 8, but this has not been demonstrated in human studies and involved doses/exposure patterns not reflective of typical clinical use.

The weight of guideline evidence from the CDC and European Respiratory Society, combined with prospective human cohort data, supports azithromycin safety for women trying to conceive. 1, 2, 4

Practical Recommendations

  • Use azithromycin when clinically indicated (e.g., chlamydia, respiratory infections, other susceptible bacterial infections) without concern about delaying conception attempts 1, 2
  • No contraceptive measures are needed during or after azithromycin therapy 1, 2
  • If treating chlamydia and pregnancy is confirmed during or shortly after treatment, repeat testing 3 weeks after therapy completion is mandatory to ensure cure 2, 6
  • Ensure sexual partners are treated to prevent reinfection, which is a common cause of apparent treatment failure 2, 6

References

Guideline

Azithromycin Safety in First Trimester of Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Azithromycin Use in Pregnancy – Evidence‑Based Guideline Summary

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Chlamydia in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.